About the Author(s)

Justus U. Onu Email symbol
Department of Mental Health, Faculty of Medicine, Nnamdi Azikiwe University, Awka, Nigeria

Portia N. Osuji symbol
Department of Neurosurgery, University College Hospital, Ibadan, Nigeria


Onu JU, Osuji PN. Double burden of malnutrition amongst patients with first-episode schizophrenia in a psychiatric hospital: A 1-year follow-up study. S Afr J Psychiat. 2020;26(0), a1564. https://doi.org/10.4102/sajpsychiatry.v26i0.1564

Original Research

Double burden of malnutrition amongst patients with first-episode schizophrenia in a psychiatric hospital: A 1-year follow-up study

Justus U. Onu, Portia N. Osuji

Received: 19 May 2020; Accepted: 14 Aug. 2020; Published: 10 Nov. 2020

Copyright: © 2020. The Author(s). Licensee: AOSIS.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Background: Despite the burgeoning data on the double burden of malnutrition (DBM) in sub-Saharan Africa, longitudinal studies to examine malnutrition amongst first-episode schizophrenia are uncommon in the modern literature.

Aim: To determine the extent of nutritional variations amongst persons with schizophrenia at intervals of 1-year treatment follow-up.

Setting: This study was conducted at the Federal Neuropsychiatric Hospital, Enugu, Nigeria.

Methods: Consecutive incident cases that fulfilled the criteria for schizophrenia were recruited into the study. After a baseline assessment, 206 incident cases of schizophrenia were followed up at 4th, 8th, 12th weeks, 6 months and 1 year for indicators of nutritional outcome. The body mass index (BMI) was used to measure the nutritional status amongst the study participants. Changes in the BMI across intervals of follow-up were examined using repeated measures analysis of variance, whereas the socio-demographic and clinical variables were evaluated as predictors of outcome using multiple regression analysis.

Results: After 1 year of treatment with antipsychotics, the prevalence of underweight decreased from 19.9% (95% CI, 19.8% – 20.0%) at baseline to 16.0% (95% CI, 15.9% – 16.1%) at 1 year, but the prevalence of overweight/obesity increased from 29.1% (95% CI, 29.0% – 29.2%) at baseline to 43.2% (95% CI, 43.0% – 43.3%) at 1 year of follow-up. The predictors of BMI at 1 year were antipsychotic medication (32.7% variance), duration of vagrancy (24.0%) and age at onset (20.0%).

Conclusion: The finding of coexistence of undernutrition and overnutrition across the intervals of treatment follow-up underscores the need for comprehensive interventions to address both extremes of malnutrition amongst patients with schizophrenia.

Keywords: burden; double; malnutrition; first-episode; schizophrenia.


The concept of double burden of malnutrition (DBM) first emerged in 1992 and was defined as the coexistence of both undernutrition and overnutrition or diet-related non-communicable diseases (NCDs) in the same individual, household or a population across the life course.1 Double malnutrition affects all countries and socio-economic class, and the drivers have been summarised in the various changes the world is experiencing, namely nutrition, demographic and epidemiological transition.1 In sub-Saharan Africa, DBM poses a real and growing health challenge with high levels of undernutrition and a rising burden of overweight and obesity and diet-related NCDs.2

Schizophrenia is a chronic disorder affecting about 1% of the population with heterogeneous treatment outcome.3 There are reports of widening mortality gap amongst patients with schizophrenia in comparison with the general population.4 The higher risk of mortality amongst this population has been explained by various factors, including nutrition.5 Nutrition is recognised as a key determinant of well-being and a contributor to human capital development.2 There is growing evidence that nutrition may be of central importance to the manifestation of schizophrenia.6,7 The exact nature of the relationship between nutrition and various facets of the disease is not clear.8 Various authors suggest a complex dynamic relationship in relation to cause, effect and prognostic importance.6,7,8,9

Historically, famine and starvation were the common causes of malnutrition and have remained so till date. A growing concern is the malnutrition related to diseases, especially chronic physical and mental disorders.8,10,11 Psychiatric patients are known to have increased risk of malnutrition,12,13,14 yet physical examinations and nutritional assessments are not routinely performed and followed up by psychiatrists and other mental health professionals.15 Although literature on the DBM amongst patients with schizophrenia is sparse globally,16 Sugai et al.13 reported the prevalence of underweight and overweight + obesity amongst patients with schizophrenia in a Japanese psychiatric hospital as 13.8% and 30.2%, respectively. Although most previous studies have centred their findings on the indices of overnutrition (i.e. overweight and obesity) and metabolic disturbances amongst patients with schizophrenia;5,17 emerging evidence shows that underweight (i.e. undernutrition) is increasingly being recognised as a health risk which can lead to increased mortality.18 A recent meta-analysis of studies that specifically mentioned underweight amongst patients with schizophrenia identified only 17 studies globally with majority (23.5%) of them amongst Japanese in-patients.16 This study reported a pooled prevalence of underweight of 6.2%.16 However, when these studies were dichotomised between Japanese and non-Japanese populations, the pooled prevalence was 17.6% and 4.6%, respectively.16

In response to the malady of malnutrition in the population, the United Nations Decade of Action on Nutrition and Sustainable Development Goals’ double-duty actions has simultaneously and synergistically addressed undernutrition and overweight, obesity and diet-related NCDs more especially in the sub-Saharan Africa.1 Despite this, there is a paucity of data on the burden of double malnutrition amongst patients with schizophrenia receiving treatment in Nigeria. In Europe and North America, patients with schizophrenia treated with antipsychotic medications have a high prevalence of obesity and metabolic syndrome.5 However, in Africa, the burden of undernutrition remains huge with co-existing overnutrition.2 In the light of these issues, the following research questions became pertinent to nutritional research amongst patients with schizophrenia in Africa:

  • What proportions of patients with schizophrenia have different levels of nutritional status (i.e. underweight, normal and overnutrition (defined in the methodology section) at each interval of 1-year treatment follow-up?
  • What are the socio-demographic, clinical and psychosocial (including social support) predictors of nutritional outcome at 1-year of treatment follow-up?

Materials and methods

Study design and population

The details of the study methodology have been published elsewhere.19 However, this was a longitudinal naturalistic treatment follow-up study, carried out amongst the incident cases of schizophrenia for various nutritional outcomes. Consecutive incident cases of schizophrenia seen in the study centre were recruited into the study and followed up for 1 year. Patients aged 18–60 years were included in the study. Patients with schizophrenia of suspected organic aetiology or with medical or psychiatric comorbidities were excluded. As this was a naturalistic and observational study, the researcher did not attempt to interfere with the treatment measures put in place by the managing team. However, the treatments and investigations were documented.

Diagnostic interview

Diagnosis of schizophrenia was made using the ICD-10 criteria for schizophrenia and confirmed using the Mini International Neuropsychiatric Interview (MINI). First, using the screening sections of the modules of the MINI, the researcher sought to screen out the presence of comorbid major mental disorders. A detailed medical history with full physical examination (including neurological examination) was conducted to exclude the presence of comorbid physical conditions.

Thereafter, the socio-demographic questionnaire was administered; this questionnaire contained items to assess socio-demographic characteristics and other nutritional variables (e.g. food refusal, changes in appetite and eating of non-nutritious materials).

The body mass index (BMI) or the Quetelet Index, which is a measure of weight in kilogram divided by height in metre squared, was used to determine the nutritional status across the intervals of treatment follow-up. The BMI has been known as a reliable measure of body proportions and composition, thinness or undernutrition.20 In 1992, a task force of the International Dietary Energy Consultative Group subcommittee on nutrition suggested that BMI should be used to define adult chronic dietary deficiency.21 The great advantage of this index is the ease of use, the low cost, the good correlation with the fat mass and the association with morbidity and mortality.22 In this study, nutritional status was classified using the cut-off of BMI score proposed by the World Health Organization as follows: underweight (BMI score less than 18.5 kg/m2), normal (BMI score 18.5–24.9 kg/m2), overweight (BMI ≥ 25 kg/m2) and obesity (BMI ≥ 30 kg/m2).23 However, undernutrition was the term used for underweight, whereas overnutrition was used for the categories of overweight and obesity.

The baseline assessments were completed at the emergency and crisis intervention unit or within 1 week of admission for admitted participants. The baseline weight and height were assessed, and BMI was calculated using the BMI formula (i.e. weight (in kg)/height squared (in meter). In addition, clinical severity of symptoms were rated using the Positive and Negative Symptoms Scale (PANSS),24 whereas the social support was assessed using the Multi-dimensional Scale of Perceived Social Support (MSPSS).25 This was applied when the patient was judged to have become clinically stable and able to complete the questionnaire. The Social Support Scale was either given to the patient or read aloud for the patient to indicate the answer as it applied to him or her.

For follow-up, participants were assessed at 4th, 8th, 12th weeks, 6 months and 1 year after the baseline. Participants were assessed using all the variables as described for the baseline assessment. Participants who missed their appointment were traced using phone numbers, family contact and next of kin’s address or phone number. A record of participants lost to follow-up was made.

Data analysis

The statistical analysis was performed using the Statistical Package for Social Sciences, version 20 (IBM-SPSS 20). Data were entered and analysed based on the last observation carried forward (LOCF). Repeated measures analysis of variance was used to assess significant differences in change in BMI scores across the period of follow-up. The relationship between BMI at baseline, age at onset, duration of vagrancy, clinical severity and social support was assessed using Spearman’s correlation analysis. Multivariate analyses using step-wise multiple regressions were used to assess the predictors of nutritional outcome (BMI at 1 year follow-up). All tests of significance were two-tailed at the 5% level of significance and confidence interval estimation of 95%.

Ethical consideration

Approval for this study was obtained from the Ethics and Research Committee of the Federal Neuropsychiatric Hospital, Enugu, Enugu State, Nigeria, with reference number FNHE/HTR/REA/VOL.11/356. This was approved on 15 August 2017 as part of a larger study on nutritional outcome of patients with schizophrenia. International ethical norms and standards were strictly adhered to at all times. Verbal and written consent were obtained from all the participants. Participation was voluntary.


Table 1 shows the socio-demographic characteristics of the 206 schizophrenia participants. The study participants were mostly young (mean age 26 years), females (58.7%), single (63.6%), had high school education (56.0%) and employed (57.8%). Table 2 shows the prevalence of underweight at baseline, 4th, 8th, 12th week, 6 months and 1 year (95% CI) were 19.9% (19.8% – 20.0%), 17.0% (16.9% –17.1%), 16.5% (16.4% – 16.7%), 16.0% (15.9% – 16.1%), 16.0% (15.9% – 16.1%) and 16.0% (15.9% – 16.1%), respectively. The prevalence of overnutrition (overweight + obesity) at baseline, 4th, 8th, 12th week, 6 months and 1 year (95% CI) were 29.1% (29.0% – 29.2%), 36.9% (36.8% – 37.0%), 39.3% (39.2% – 39.4%), 40.3% (40.2% – 40.5%), 41.7% (41.6% – 41.8%) and 43.2% (43.0% – 43.3%), respectively.

TABLE 1: Socio-demographic and clinical characteristics of the study participants, N = 206.
TABLE 2: Nutritional status across the intervals of treatment follow-up using last observation carried forward and real attrition data.

Table 3 shows a progressive increase in weight across the intervals of treatment follow-up and 80.6% of the participants had greater than 5% increase in weight at 1 year follow-up. Similarly, there was a significant increase in the BMI across the intervals of follow-up (F = 49.65; p < 0.001; partial eta squared = 0.3). Pairwise comparison shows that the significant difference was across most of the intervals (p < 0.001), and the exceptions were between 8th week and 12th week (p = 0.25) and between 12th week and 6 months (p = 0.41) as shown in Figure 1.

FIGURE 1: Change in the body mass index across the intervals of follow-up.

TABLE 3: Description of weight changes across the intervals of follow-up.

The age at onset, duration of vagrancy, baseline BMI and antipsychotic medications were significant predictors of the BMI at 1 year, and they contributed 20.0%, 24.0%, 25.3% and 32.7%, respectively, of the variance as shown in Table 4.

TABLE 4: Relationship between body mass index at 1 year and body mass index at baseline, duration of vagrancy, age at onset, social support and disease severity.


The study was aimed at a naturalistic treatment follow-up of 206 incident cases of schizophrenia over 1-year period, with a view to highlight the burden of double malnutrition and to examine the potential predictors of nutritional status at 1 year.

This study is amongst the few African studies to examine the DBM amongst patients with schizophrenia using incident cases in a longitudinal design. The major strengths of the study are as follows: First, incident cases, predominantly neuroleptic naïve at the baseline were used to overcome the methodological problems inherent in prevalent and/or chronic cases. Second, they were followed-up for relatively a long period of 1 year using a well-validated measure of nutritional status.

The main findings of this study were as follows: (1) the DBM was evident across the intervals of treatment follow-up. The prevalence of undernutrition (i.e. underweight) and overnutrition (i.e. overweight + obesity) amongst the study participants were at baseline (19.9% vs. 29.1%), 4th week (17.0% vs. 36.9%), 8th week (16.5% vs. 39.3%), 12th week (16.0% vs. 40.3%), 6 months (16.0% vs. 41.7%) and 1 year (16.0% vs. 43.2%), respectively. (2) There was a progressive increase in weight and BMI across the intervals of treatment follow-up and (3) the age at onset, duration of vagrancy, being on antipsychotic medication and baseline BMI were predictors of nutritional outcome at 1 year.

The finding of the baseline prevalence of underweight and overweight + obesity of 19.9% and 29.1%, respectively, is consistent with previous reports.13,14 Assefa et al.14 in a cross-sectional study of patients with psychiatric disorders in an Ethiopian psychiatric hospital reported a prevalence of 20.0% and 23.4% for underweight and overweight + obesity, respectively. These studies share some similarities in the sense that the prevalence of overnutrition was higher than that of undernutrition in both studies. Additionally, both inpatient and outpatient were considered, and nutritional status was assessed using similar measure (i.e. the BMI). However, there are some methodological differences. For example, first-episode cases were used in this study unlike prevalent cases used in the Ethiopian study. More so, this study used a longitudinal design as against the cross-sectional design of the former. In addition, only patients with schizophrenia were included in this study, whereas the Ethiopian study used a heterogeneous group of people with mental disorders. This shows that this study is more likely to give a clearer picture of the nutritional status of patients with schizophrenia. Similarly, the finding of the higher prevalence of overnutrition when compared with undernutrition in this study is consistent with other international studies.13,26 Amongst Japanese patients with schizophrenia, Sugai et al.13 reported a prevalence of 13.8% and 30.2%, respectively, for undernutrition (i.e. underweight) and overnutrition (overweight + obesity). The lower prevalence of underweight of 13.8% amongst patients with schizophrenia in Japan when compared with 19.9% in this study may be explained by biological and sociocultural factors.27 Indeed, some authors have shown a higher prevalence of thin body build amongst Asian populations, and it is recommended that a lower BMI cut-off point should be used for Asian populations.28 Furthermore, the Japanese study was done amongst inpatients who are more likely to have severe disease. Interestingly, the prevalence of underweight and overweight + obesity across the intervals of treatment of follow-up was higher than the previously reported prevalence of underweight (2.0%) and overweight + obesity (26%) amongst community population in Nigeria.29 There are plausible explanations of the higher prevalence of underweight amongst patients with schizophrenia in this study when compared with that reported amongst the community population of Nigerians. First, the symptoms of the disease (e.g. anhedonia, loss of appetite, amotivation and easy fatigability) may limit food intake and lead to undernutrition. Similarly, positive symptoms of excitement may increase energy expenditure leading to a state of increased catabolism. Second, psychosocial difficulties such as poor social support, loss of employment and other indices of social disadvantage common amongst this population may limit the capacity of affected individual to have access to optimal nutrition. Third, biological factors such as chronic inflammation (e.g. gluten sensitivity), which is known to be common amongst patients with schizophrenia, may cause malabsorption and lead to undernutrition.6 Similarly, the higher prevalence of overweight and obesity amongst patients with schizophrenia when compared with the previous community prevalence in Nigeria (29.1% vs. 26.0%) could be explained by genetic, lifestyle and medication factors.5,17 However, it is noteworthy to state that although the proportion of patients with underweight decreased with treatment and a subsequent rise in the proportion of overweight + obese patients, both states coexisted throughout the intervals of treatment follow-up.

Another important finding in this study is the progressive reduction in the prevalence of undernutrition with treatment. In other words, there was a progressive increase in weight and BMI across the intervals of treatment follow-up. This finding is consistent with the robust reports in the literature that with treatment, there is a progressive increase in weight and BMI.5,17 This increase in weight as highlighted earlier can be explained by lifestyle factors, medications and inherent biological factors. It is also possible that with improvement in symptoms, patients’ appetite may improve and indices of social advantage restored; these factors may interact to improve nutritional status.

Concerning the predictors of nutritional status at 1 year, this study found that the age at onset of disease, duration of vagrancy, baseline body mass and use of antipsychotic medications were significant predictors of 1-year BMI. Previous studies have demonstrated that mental symptoms were significant risk factors of malnutrition amongst patients with mental disorders.19,30 Contrary to these previous reports, this study demonstrated a weak negative non-significant relationship between dimensions of psychopathology and BMI at 1 year. Although a previous study identified depressive symptoms as a risk factor for undernutrition,30 this study did not explore the effect of depressive symptoms rather the dimensions of symptoms were assessed. However, similar to the findings of this study, Kim et al.12 reported that living status and baseline weight were significant predictors of malnutrition amongst community-dwelling patients with schizophrenia. Several reports in the literature have linked homelessness with nutritional status of both mentally ill and persons without mental illness.31,32 It is known that many homeless persons eat fewer meals per day, lack food more often and are more likely to have inadequate diets.31,32 Wiecha et al.31 and Halsu et al.32 reported that homelessness is an important factor associated with the quality of nutrition and nutritional status.


One of the limitations of this study was the use of institution-based samples (care seekers); although it saved cost and time and is the predominant methodology in the literature, a community sample would have been more representative. The second limitation was the use of semi-structured questionnaire to assess feeding and/or eating behaviours; a structured questionnaire would have been more appropriate. Third, this study did not examine other biochemical variables to add to its depth. Fourth, the study did not include a control group that would have compared with general population. Finally, the attrition rate in this study was 45.6%; although within the range of 30% – 70% previously reported in a meta-analysis of attrition rates in longitudinal studies,33 the characteristics of those lost to follow-up may have affected the findings of this study.


The main finding of this study is that the number of underweight patients stayed fairly similar but overweight increased over 1-year period of treatment follow-up. The finding of the coexistence of undernutrition and overnutrition amongst patients with schizophrenia underscores the need for proper nutritional assessment and a comprehensive multidisciplinary nutritional intervention to tackle the two extremes of malnutrition in this patient population.


The authors would like to thank Dr Muideen Bakare, the then Head of Training and Research, Federal Neuropsychiatric Hospital, Enugu, for providing the enabling environment and some logistic support for this study. In addition, they thank all the resident doctors of the Federal Neuropsychiatric Hospital, Enugu, for their cooperation throughout the period of the study. They are also grateful to the patients and their relatives for freely giving of their time to participate in the study.

Competing interests

The authors declare that no conflict of interest exists.

Authors’ contributions

J.U.O. and P.N.O. contributed to the study design, analysis and interpretation of data. J.U.O. drafted the manuscript. All authors read and approved the final manuscript.

Funding information

This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.

Data availability statement

The research data are available on request.


The views expressed in this article are that of the authors and not an official position of the institution where the study was carried out.


  1. United Nations Decade of Action on Nutrition. Seventieth Session of the United Nations General Assembly; 2015 Sep 15–28; New York, NY.
  2. World Health Organization. Nutrition in the WHO African region. Brazzaville: World Health Organization; 2017.
  3. Haro JM, Novick D, Bertsch J, Karagianis J, Dossenback M, Jones PB. Cross-national clinical and functional remission rates: Worldwide schizophrenia out-patient health outcome (S-SOHO) study. Br J Psychiatry. 2011;199(3):194–201. https://doi.org/10.1192/bjp.bp.110.082065
  4. Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: Is the differential mortality gap worsening over time? Arch Gen Psychiatry. 2007;64(10):1123–1131. https://doi.org/10.1001/archpsyc.64.10.1123
  5. Cassy DE. Metabolic issues and cardiovascular diseases in patients with psychiatric disorders. Am J Med. 2005;118(2):15S–22S. https://doi.org/10.1016/j.amjmed.2005.01.046
  6. Dohan FC. Cereals and schizophrenia: Data and hypothesis. Acta Psychiatr Scand. 1966;42(2):125–152. https://doi.org/10.1111/j.1600-0447.1966.tb01920.x
  7. Christensen O, Christensen E. Fat consumption and schizophrenia. Acta Psychiatr Scand. 1988;78(5):587–591. https://doi.org/10.1111/j.1600-0447.1988.tb06388.x
  8. Peet M. Nutrition and schizophrenia: An epidemiological and clinical perspective. Nutr Health. 2003;17(3):211–219. https://doi.org/10.1177/026010600301700304
  9. Zeman F. Clinical nutrition and dietetics. 2nd ed. New York, NY: Macmillan Publishing Company, 1991; p. 701–736.
  10. Heys SD, Schofield AC, Wahle KW, Garcia-Caballero M. Nutrition and the surgical patient: Triumphs and challenges. Surgeons. 2005;3(3):139–144. https://doi.org/10.1016/s1479-666x(05)80033-2
  11. Warnold I, Lundholm K. Clinical significance of preoperative nutritional status in 215 noncancer patients. Ann Surg. 1984;199(3):299–305. https://doi.org/10.1097/00000658-198403000-00009
  12. Kim SR, Kim JY, Kim HY, Nho JU, Kim YH, Min SY. Factors related to malnutrition in community-dwelling patients with schizophrenia. Perspect Psychiatr Care. 2019;55(3):415–423. https://doi.org/10.1111/ppc.12327
  13. Sugai T, Suzuki Y, Yamazaki M, et al. High prevalence of underweight and undernutrition in Japanese inpatients with schizophrenia: A nationwide survey. BMJ Open. 2015;5(12):e008720. https://doi.org/10.113/bmjopen-2015-008720
  14. Assefa T, Seid O, Tadese F, Gebremedhin T. Nutritional status and associated factors among adult psychiatric patients in Dessie referral hospital, Northeast-Ethiopia. Psychiatry J. 2020(3):5087573. https://doi:org/10.1155/2020/5087573
  15. Patterson CW. Psychiatrists and physical examinations: A survey. Am J Psychiatry. 1978;135(8):967–968. https://doi.org/10.1176/ajp.135.8.967
  16. Sugawara N, Maruo K, Sugai T, et al. Prevalence of underweight in patients with schizophrenia: A meta-analysis. Schizophr Res. 2018;195(1):67–73. https://doi.org/10.1016/j.schres.2017.10.017
  17. Ighoroje M, Ogundele A, Abayomi O. Obesity and pattern of use of antipsychotic agents among outpatients with schizophrenia in Nigeria. Int J Psychiat Clin. 2017;5(2):32–38. https://doi.org/10.5923/j.ijcp.20170502.02
  18. Wirth R, Streicher M, Smoline C, et al. The impact of weight loss and low BMI on mortality of nursing home residents-results from nutrition day in nursing homes. Clin Nutr. 2016;35(4):900–906. https://doi.org/10.1016/j.clnu.2015.06.003
  19. Osuji PN, Onu JU. Feeding behaviors among incident cases of schizophrenia in a psychiatric hospital: Association with dimensions of psychopathology and social support. Clin Nutr ESPEN. 2019;34(1):125–129. https://doi.org/10.1016/j.cinesp.2019.08.001
  20. Norgan NG. Body mass index and body energy stores in developing countries. Eur J Clin Nutr. 1990;44(1):79–84.
  21. Norgan NG. Population differences in body composition in relation to BMI. Eur J Clin Nutr. 1994;48(3):S10–S12.
  22. Cervi A, Franceschini SCC, Priore SE. Critical analysis of the use of the body mass index for the elderly. Rev Nutr. 2005;18(6):765–775. https://doi.org/10.1590/S1415-52732005000600007
  23. World Health Organization. Obesity: Preventing and managing the global epidemic. Geneva: World Health Organization, 1998; p. 276.
  24. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261–276. https://doi.org/10.1093/schbul/13.2.261
  25. Zimet GD, Dahlem NW, Zimet SG, Farley GK. The multidimensional scale of perceived social support. J Pers Assess. 1988;52(1):30–41. https://doi.org/10.1207/s15327752jpa5201_2
  26. Yutaro S, Sugai T, Fukui N, Watanabe J, Ono S, Tsuneyama N. High prevalence of underweight and undernutrition in Japanese inpatients with schizophrenia. Psychiat Clin Neuros. 2014;68(1):78–82. https://doi.org/10.1111/pcn.12082
  27. Caprio S, Daniels SR, Drewnowski A, Kaufman FR, Palinkas LA, Rosenbloom AL. Influence of race, ethnicity, and culture on childhood obesity: Implication for prevention and treatment. Diabetes Care. 2008;31(11):2211–2221. https://doi.org/10.2337/dc08-9024
  28. Choo V. WHO reassesses appropriate body mass index for Asian populations. Lancet. 2002;360(9328):235. https://doi.org/10.1016/S0140-6736(02)09512-0
  29. Sola AO, Steven AO, Kayode JA, Olayinka AO. Underweight, overweight and obesity in adult Nigerians living in rural and urban communities of Benue State. Ann Afr Med. 2011;10(2):139–143. https://doi.org/10.4103/1596-3519.82081
  30. Li IC, Kuo HT, Lin YC. The mediating effect of depressive symptoms on nutritional status of older adults in long term care facilities. J Nutr Health Aging. 2013;17(7):633–636. https://doi.org/10.1007/s12603-013-0018-7
  31. Wiecha JL, Dwyer JT, Dunn-Strohecter M. Nutrition and health services needs among the homeless. Public Health Rep. 1991;106(4):364–374.
  32. Halsu I, Gunther C, Hade E, Vandergriff S, Slesnick N, Williams R. Unaccompanied homeless youth have extremely poor food quality and nutritional status. Int J Adolesc Youth. 2019;24(3):1–24. https://doi.org/10.1080/02673843.2018.1538885
  33. Fischer EH, Dornelas EA, Goethe JW. Characteristics of people lost to attrition in psychiatric follow-up studies. J Nerv and Ment Dis. 2001;189(1):49–55. https://doi.org/10.1097/00005053-200101000-00009


Crossref Citations

1. Malnutrition and perspectives of nutritional therapy for mental disorders
D. V. Romanov, K. Yu. Dmitrenko
Neurology, Neuropsychiatry, Psychosomatics  vol: 13  issue: 2  first page: 137  year: 2021  
doi: 10.14412/2074-2711-2021-2-137-143